| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| HUANG JEN HSUN | President and CEO, Director | C/O NVIDIA CORPORATION, 2788 SAN TOMAS EXPRESSWAY, SANTA CLARA | /s/ Rebecca Peters, Attorney-in-Fact for Jen-Hsun Huang | 2025-09-16 | 0001197649 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVDA | Common Stock | Sale | -$2.53M | -14.2K | -0.02% | $177.25 | 72.2M | Sep 12, 2025 | Direct | F1, F2 |
| transaction | NVDA | Common Stock | Sale | -$10.8M | -60.6K | -0.08% | $177.83 | 72.1M | Sep 12, 2025 | Direct | F1, F3 |
| transaction | NVDA | Common Stock | Sale | -$22.5K | -126 | 0% | $178.53 | 72.1M | Sep 12, 2025 | Direct | F1, F4 |
| transaction | NVDA | Common Stock | Sale | -$3.75M | -21.4K | -0.03% | $175.23 | 72.1M | Sep 15, 2025 | Direct | F1, F5 |
| transaction | NVDA | Common Stock | Sale | -$2.02M | -11.5K | -0.02% | $175.94 | 72.1M | Sep 15, 2025 | Direct | F1, F6 |
| transaction | NVDA | Common Stock | Sale | -$6.6M | -37.2K | -0.05% | $177.37 | 72M | Sep 15, 2025 | Direct | F1, F7 |
| transaction | NVDA | Common Stock | Sale | -$875K | -4.92K | -0.01% | $177.87 | 72M | Sep 15, 2025 | Direct | F1, F8 |
| transaction | NVDA | Common Stock | Sale | -$6.38M | -36.5K | -0.05% | $174.98 | 72M | Sep 16, 2025 | Direct | F1, F9 |
| transaction | NVDA | Common Stock | Sale | -$3.58M | -20.3K | -0.03% | $176.10 | 72M | Sep 16, 2025 | Direct | F1, F10 |
| transaction | NVDA | Common Stock | Sale | -$3.11M | -17.6K | -0.02% | $176.60 | 71.9M | Sep 16, 2025 | Direct | F1, F11 |
| transaction | NVDA | Common Stock | Sale | -$102K | -577 | 0% | $177.39 | 71.9M | Sep 16, 2025 | Direct | F1, F12 |
| transaction | NVDA | Common Stock | Gift | $0 | -1.13M | -0.19% | $0.00 | 581M | Sep 15, 2025 | By Trust | F13, F14 |
| holding | NVDA | Common Stock | 49.5M | Sep 12, 2025 | By Partnership | F15 | |||||
| holding | NVDA | Common Stock | 22.3M | Sep 12, 2025 | By Irrevocable Trust | F16 | |||||
| holding | NVDA | Common Stock | 50.1M | Sep 12, 2025 | By Irrevocable Remainder Trust | F17 | |||||
| holding | NVDA | Common Stock | 29.5M | Sep 12, 2025 | By Grantor Retained Annuity Trust 1 | F18 | |||||
| holding | NVDA | Common Stock | 29.5M | Sep 12, 2025 | By Grantor Retained Annuity Trust 2 | F19 | |||||
| holding | NVDA | Common Stock | 10M | Sep 12, 2025 | By Limited Liability Company 1 | F20 | |||||
| holding | NVDA | Common Stock | 10M | Sep 12, 2025 | By Limited Liability Company 2 | F21 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 20, 2025. |
| F2 | Represents weighted average sales price. The shares were sold at prices ranging from $176.530 to $177.525. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Represents weighted average sales price. The shares were sold at prices ranging from $177.530 to $178.520. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Represents weighted average sales price. The shares were sold at prices ranging from $178.530 to $178.540. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Represents weighted average sales price. The shares were sold at prices ranging from $174.580 to $175.575. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Represents weighted average sales price. The shares were sold at prices ranging from $175.580 to $176.485. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Represents weighted average sales price. The shares were sold at prices ranging from $176.750 to $177.740. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Represents weighted average sales price. The shares were sold at prices ranging from $177.750 to $178.210. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F9 | Represents weighted average sales price. The shares were sold at prices ranging from $174.400 to $175.390. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F10 | Represents weighted average sales price. The shares were sold at prices ranging from $175.410 to $176.400. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F11 | Represents weighted average sales price. The shares were sold at prices ranging from $176.410 to $177.090. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F12 | Represents weighted average sales price. The shares were sold at prices ranging from $177.290 to $177.410. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F13 | Gifts without consideration by Jen-Hsun Huang and Lori Huang, as co-trustees of the Jen-Hsun & Lori Huang Living Trust, u/a/d May 1, 1995 (the "Trust"), of 750,000 shares of the Issuer's common stock to The Jen-Hsun & Lori Huang Foundation, a 501(c)(3) charitable organization, and 375,000 shares of the Issuer's common stock to a donor-advised fund. |
| F14 | The shares are held by Jen-Hsun Huang and Lori Huang, as co-trustees of the Trust. |
| F15 | The shares are held by J. and L. Huang Investments, L.P., of which the Trust is the general partner. |
| F16 | The shares are held by The Huang 2012 Irrevocable Trust, of which the Reporting Person is a trustee. |
| F17 | The shares are held by The Huang Irrevocable Remainder Trust u/a/d February 19, 2016, of which the Reporting Person is a trustee. |
| F18 | The shares are held by The Lori Lynn Huang 2016 Annuity Trust II Agreement. |
| F19 | The shares are held by The Jen-Hsun Huang 2016 Annuity Trust II Agreement. |
| F20 | The shares are held by TARG S LLC, of which the Trust is the sole member. |
| F21 | The shares are held by TARG M LLC, of which the Trust is the sole member. |